Leicester General Hospital is a National Health Service hospital located in the suburb of Evington, about three miles east of Leicester City Centre, and is a part of University Hospitals of Leicester NHS Trust. It has approximately 430 beds. The hospital is the largest employer in the area.

There are 430 beds in Leicester General Hospital.

During the past decade, Leicester General Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 11 clinical trials were completed, i.e. on average, 52.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Leicester General Hospital" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "University Hospitals, Leicester" with 4 trials sponsored, "University of Oxford" with 3 trials sponsored and "Institute of Cancer Research, United Kingdom" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Leicester General Hospital" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Arbeitsgruppe Lebermetastasen und Tumoren" with 1 trials as a collaborator, "Arthritis Research UK" with 1 trials as a collaborator, "B. Braun Melsungen AG" with 1 trials as a collaborator and "Barts and the London School of Medicine and Dentistry" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Leicester General Hospital" are "Prostate Cancer" (4 trials), "Diabetes Mellitus" (3 trials), "Diabetes Mellitus, Type 1" (3 trials), "Chronic Kidney Disease" (2 trials) and "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Leicester General Hospital" in a lesser frequency.

Most popular intervention types in "Leicester General Hospital" are "Drug" (29 trials), "Procedure" (10 trials), "Other" (5 trials), "Biological" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Tirzepatide" (4 trials), "Empagliflozin" (2 trials), "adjuvant therapy" (2 trials) and "conventional surgery" (2 trials). Other intervention names were less common.

The vast majority of trials in "Leicester General Hospital" are 39 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Leicester General Hospital". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Leicester General Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Leicester General Hospital, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".